Clinical Trial Update: Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating AST-120 in non-constipating irritable bowel syndrome reports safety and efficacy results. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• AST-120 (AST-120)

Snippet

Sponsor: Ocera Therapeutics | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED